Compared to the untreated condition, continuous and post-infection treatment with MK-8722 increased IFNα mRNA expression by 100% ± 38% and 140% ± 58% (Kruskal-Wallis: P < 0.05 for both treatments) while that of IFNβ decreased by 73% ± 5% and 45% ± 11% for continuous and post-infection treatment, respectively (Kruskal-Wallis: P < 0.01 and ns, respectively). The gene discussed is IFNA1; the disease is infection.